Litzka Olivier has filed 3 insider transactions across 1 company since February 2023.
Most recent transaction: a grant/award of 22000 shares of Mineralys Therapeutics, Inc. ($MLYS) on May 22, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 22, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Litzka Olivier | Director | A | Stock Option | 22000 | $0.00 | 22,000.0000 | 0 | 9999.99% | 0.00% |
| April 27, 2023 | Mineralys Therapeutics, Inc. | $MLYS | Litzka Olivier | Director | J | Stock Option | 44000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 9, 2023 | Mineralys Therapeutics, Inc. | $MLYS | Litzka Olivier | Director | A | Stock Option | 44000 | $0.00 | 44,000.0000 | 0 | 9999.99% | 0.00% |